We are live on
!
Find out more
DC
Decheng Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
299.97%
This Fund
S&P 500
This Quarter
Est. Return
-23.65%
1 Year Est. Return
+299.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$356M
AUM Growth
-$110M
(-24%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
6.11%
Top 10 Holdings %
Top 10 Hldgs %
86.5%
Holding
29
New
1
Increased
2
Reduced
8
Closed
2
Top Buys
| 1 |
AARD
Aardvark Therapeutics
AARD
|
+$44M |
| 2 |
Aclaris Therapeutics
ACRS
|
+$3.79M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
+$373K |
Top Sells
| 1 |
Illumina
ILMN
|
+$8.99M |
| 2 |
Phathom Pharmaceuticals
PHAT
|
+$5.64M |
| 3 |
ACLX
Arcellx
ACLX
|
+$2.33M |
| 4 |
BioNTech
BNTX
|
+$2.24M |
| 5 |
Krystal Biotech
KRYS
|
+$1.98M |
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CG Oncology
CGON
$6.44B
| $156M | 43.77% |
6,371,669
| – | – |
|
2
Nuvation Bio
NUVB
$2.05B
| $45.7M | 12.81% |
25,954,439
| – | – |
|
|
AARD
3
Aardvark Therapeutics
AARD
$146M
| $29.4M | 8.25% |
+3,917,299
| New | +$44M |
|
|
UPB
4
Upstream Bio Inc
UPB
$396M
| $20.1M | 5.64% |
3,285,293
| – | – |
|
5
NewAmsterdam Pharma
NAMS
$3.74B
| $15.8M | 4.42% |
770,000
| – | – |
|
|
6
Krystal Biotech
KRYS
$10.3B
| $11.7M | 3.29% |
65,000
-11,772
| -15% | -$1.98M |
|
7
Revolution Medicines
RVMD
$39.2B
| $7.99M | 2.24% |
226,000
| – | – |
|
|
MRUS
8
DELISTED
Merus
MRUS
| $7.96M | 2.23% |
189,098
| – | – |
|
9
BeyondSpring
BYSI
$52.2M
| $6.97M | 1.96% |
4,882,651
| – | – |
|
10
MoonLake Immunotherapeutics
MLTX
$1.67B
| $6.7M | 1.88% |
171,600
| – | – |
|
11
Lyell Immunopharma
LYEL
$349M
| $6.41M | 1.8% |
595,467
| – | – |
|
12
Arcus Biosciences
RCUS
$3.52B
| $6.35M | 1.78% |
808,789
| – | – |
|
|
13
Aclaris Therapeutics
ACRS
$782M
| $6.18M | 1.73% |
4,041,736
+1,775,069
| +78% | +$3.79M |
|
|
14
Crinetics Pharmaceuticals
CRNX
$8.88B
| $5.97M | 1.67% |
177,958
+10,000
| +6% | +$373K |
|
15
Cytokinetics
CYTK
$11.2B
| $4.02M | 1.13% |
100,000
| – | – |
|
16
Legend Biotech
LEGN
$4.46B
| $3.39M | 0.95% |
100,000
-53,558
| -35% | -$1.92M |
|
|
ACLX
17
DELISTED
Arcellx
ACLX
| $3.28M | 0.92% |
50,000
-34,377
| -41% | -$2.33M |
|
18
Zentalis Pharmaceuticals
ZNTL
$340M
| $3.21M | 0.9% |
2,019,762
-318,333
| -14% | -$686K |
|
19
Aura Biosciences
AURA
$725M
| $3.02M | 0.85% |
515,555
| – | – |
|
|
20
BioNTech
BNTX
$23.3B
| $1.82M | 0.51% |
20,000
-20,000
| -50% | -$2.24M |
|
21
Equillium
EQ
$166M
| $1.74M | 0.49% |
4,447,308
| – | – |
|
22
4D Molecular Therapeutics
FDMT
$611M
| $1.08M | 0.3% |
335,515
-64,485
| -16% | -$304K |
|
|
23
Illumina
ILMN
$28.3B
| $932K | 0.26% |
11,749
-83,018
| -88% | -$8.99M |
|
24
Pyxis Oncology
PYXS
$154M
| $320K | 0.09% |
326,810
| – | – |
|
|
GRAL
25
GRAIL Inc
GRAL
$3.19B
| $247K | 0.07% |
9,684
| – | – |
|
Similar funds
TPM
AWA
FAM
OL
GC
HIG
RCG
AWM